SCHEMBL3979332

SCHEMBL3979332

CC[C@H]1CN(C(C)c2ccccc2)C[C@]1(C)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.41
ALDH1A1 P00352 3/20 0.41
KMT2A Q03164 1/20 0.39
OPRM1 P35372 2/20 0.39
OPRD1 P41143 2/20 0.39
OPRK1 P41145 2/20 0.39
OPRL1 P41146 2/20 0.39
MC4R P32245 1/20 0.38
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
TDP1 Q9NUW8 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
GABRA1 P14867 2/20 0.36
GABRB2 P47870 2/20 0.36
CYP11B1 P15538 2/20 0.36
CYP11B2 P19099 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3976441 0.82 CYP2D6 (0.45) CYP2D6ALDH1A1KMT2AOPRM1OPRD1
SCHEMBL4187954 0.82 CYP2D6 (0.45) CYP2D6ALDH1A1KMT2AOPRM1OPRD1
SCHEMBL4182073 0.82 CYP2D6 (0.45) CYP2D6ALDH1A1KMT2AOPRM1OPRD1
SCHEMBL4188990 0.81 CYP2D6 (0.44) CYP2D6ALDH1A1KMT2AOPRM1OPRD1
SCHEMBL12188091 0.77 CYP2D6 (0.42) CYP2D6ALDH1A1OPRM1OPRD1OPRK1
SCHEMBL3975897 0.77 GRIN2B (0.43) CYP2D6ALDH1A1GAACYP1A2CYP3A4
SCHEMBL3978001 0.76 OPRM1 (0.42) ALDH1A1OPRM1OPRD1OPRK1OPRL1
SCHEMBL13764767 0.75 CTSK (0.39) ALDH1A1KMT2A
SCHEMBL3976700 0.75 CTSK (0.39) ALDH1A1KMT2A
SCHEMBL3976705 0.75 CTSK (0.39) ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7563805-B2 7-[3-Amino-3,4-dimethylpyrrolidine-1-yl]-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-1,4-dihydro-8-methyl-4-oxoquinoline-3-carboxylic acid: quinoline bactericide; broad spectrum, strong antibacterial activity for Grampositive/-negative including multiple resistant cocci; side effect reductcion; drug design DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2009-07-21 US disclosed
US-20060264428-A1 Tri-, tetra-substituted-3-aminopyrrolidine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264428-A1 Tri-, tetra-substituted-3-aminopyrrolidine derivative QTRT1, RRS1, LAS1L CYP2D6 895/4885ALDH1A1 3966/4885KMT2A 2638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.